Jessamy Tiffen Australian Epigenetics Alliance Conference 2022

Jessamy Tiffen

Dr. Jessamy Tiffen leads the Melanoma Epigenetics Laboratory and is an Associate Faculty member at the Centenary Institute. She is an Honorary Senior Research Fellow at the Faculty of Health and Medicine, the University of Sydney. She has over 10 years of experience in Cancer Cell and Molecular Biology research, which focuses mainly on how dysregulation of epigenetic modifiers can govern major hallmarks of melanoma, including initiation, progression, and resistance to treatment. She is passionate to determine the crosstalk between histone modifiers, chromatin remodelling enzymes and DNA methyltransferases in normal physiology and disease development. She aims to provide new insights into these fundamental biological mechanisms, which can be targeted by novel therapeutics to improve outcomes for melanoma patients. Dr Tiffen completed her PhD in Cancer Genetics in 2011 from Sydney University with Professor John Rasko. She conducted post-doctoral training at the Sanger Institute in Cambridge under the guidance of Dr David Adams, where she became interested in the genetics of Melanoma. She has published in Nature Genetics, Cancer Research and JNCI and currently holds project grant funding from the Cancer Council of NSW. In 2022 she was awarded a Career Development Fellowship from the Cancer Institute of NSW. Dr Tiffen completed her PhD in Cancer Genetics in 2011 from Sydney University with Professor John Rasko. She conducted post-doctoral training at the Sanger Institute in Cambridge under the guidance of Dr David Adams, where she became interested in the genetics of Melanoma. She has published in Nature Genetics, Cancer Research and JNCI and currently holds project grant funding from the Cancer Council of NSW. In 2022 she was awarded a Career Development Fellowship from the Cancer Institute of NSW.